Giraff Wins AAL Forum's Prestigious "Most Promising" Award

The Swedish company Giraff Technologies and the EU AAL ExCITE-project received top honors at the annual AAL Forum, being named the "most promising" innovation of the year out of nearly 100 products and projects. The three criteria for the award were innovation, potential to improve the quality of life for older adults and market potential.

"We are excited about what this award means for Giraff Technologies and Robotdalen's initiative in Sweden to promote new businesses within Technology for Independent Life," says Erik Lundqvist, General Manager at Robotdalen. "Our mission is to identify and nurture companies like Giraff Technologies."

The Ambient Assisted Living (AAL) Forum is the EU industry organization that supports and promotes technology solutions for independent life. Its stated objectives are to extend the time that elderly people can live independently in their homes, specifically through preventing social isolation, maintaining social networks, and increasing the efficiency and productivity of care resources.

"We are pleased to select Giraff and the ExCITE project for this award," said Lena Gustafsson, President of the AAL Association. "They can bring to this industry exciting opportunities for innovation, improving the quality of life for older adults and market success, which is what the 'most promising' award is all about."

Social interaction and security with Giraff
The Giraff is a mobile telepresence solution that achieves AAL goals by extending the presence of caregivers in elderly persons' homes. It allows caregivers to virtually enter a home over the Internet and conduct a natural visit, moving freely around the home just as if they were physically present. Giraff diminishes social isolation and provides greater security at home for the elderly. "ExCITE" is the EU AAL funded project led by Örebro University in Sweden that studies the interaction of elderly with their caregivers through the Giraff device.

"We owe our thanks for this award to our users - elderly persons and their caregivers who continue to evaluate the Giraff solution and provide us with invaluable feedback," says Stephen Von Rump, CEO of Giraff Technologies AB. "And to the ExCITE researchers who help structure this feedback and enable us to evolve the Giraff from a product to a complete support service. We also owe a huge debt to Robotdalen for their continued support, helping us move from Silicon Valley in the U.S. and establish our company here in Sweden."

About AAL Forum
The Ambient Assisted Living (AAL) Forum is the EU industry organization that supports and promotes technology solutions for independent life. Its stated objectives are to extend the time that elderly people can live independently in their homes, specifically through preventing social isolation, maintaining social networks, and increasing the efficiency and productivity of care resources.

About Giraff
The Giraff Technologies mission is to enable confidence for independent life amongst elderly in the EU. It combines the Giraff telepresence device with user software, care organization administrative tools and a growing knowledge base to implement the Giraff solution in the real world of elderly care.

About Robotdalen
Robotdalen is a Swedish robotics initiative that enables commercial success of new ideas and research within robotics and automation. It focuses on solutions for industry, heavy autonomous vehicles and technology for independent life.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...